Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation

United European Gastroenterology Journal

Volumn 2, Issue 2, 2014, Pages 138-147

  Neri, Luca ^a,b   Basilisco, Guido ^b   Corazziari, Enrico ^c   Stanghellini, Vincenzo ^d   Bassotti, Gabrio ^e   Bellini, Massimo ^f   Perelli, Ilaria ^g   Cuomo, Rosario ^h  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f UNIVERSITY HOSPITAL OF PISA   (Italy)

^g Doxapharma   (Italy)

^h FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

Chronic constipation; Cost of illness study; Direct cost; Functional constipation; Healthcare utilization; Indirect cost; Irritable bowel syndrome; Productivity loss

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; CHRONIC CONSTIPATION; DEVELOPMENTAL STABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; IRRITABLE COLON; JOB PERFORMANCE; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM;

EID: 85006198854     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640614528175     Document Type: Article

References (40)

1. Stewart WF, Liberman JN, Sandler RS, et al. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 1999; 94: 3530–3540.
2. Higgins P and Johanson J. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004; 99: 750–759.
3. Gaburri M, Bassotti G, Bacci G, et al. Functional gut disorders and health care seeking behavior in an Italian non-patient population. Recenti Prog Med 1989; 80: 2414.
4. Peppas G, Alexiou VG, Mourtzoukou E, et al. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol 2008; 8: 5.
5. Johanson JF and Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther 2007; 25: 599–608.
6. Wald A, Kamm M, Mueller-Lissner S, et al. The BI Omnibus study: an international survey of community prevalence of constipation and laxative use in adults. Gastroenterology 2006; 130: 508.
7. Wald A, Scarpignato C, Kamm MA, et al. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther 2007; 26: 227–236.
8. Dennison C, Prasad M, Lloyd A, et al. The health-related quality of life and economic burden of constipation. Pharmacoeconomics 2005; 23: 461–476.
9. Varma MG, Wang JY, Berian JR, et al. The constipation severity instrument: a validated measure. Dis Colon Rectum 2008; 51: 162–172.
10. Sun SX, Dibonaventura M, Purayidathil FW, et al. Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey. Dig Dis Sci 2011; 56: 2688–2695.
11. Wong RK, Palsson OS, Turner MJ, et al. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol 2010; 105: 2228–2234.
12. Frank L, Kleinman L, Farup C, et al. Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol 1999; 34: 870–877.
13. Marquis P, De La Loge C, Dubois D, et al. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol 2005; 40: 540–551.
14. Apolone G, Mosconi P and Quattrocchi L. Questionario sullo stato di salute SF-12, versione italiana. Edited by Guerini e Associati, 2005. ISBN: 8883352017.
15. Derogatis LR. Symptom checklist-90-R: administration, scoring, and procedures manual, 3rd edn. Minneapolis, MN: National Computer Systems, 1994.
16. Atkinson MJ, Kumar R, Cappelleri JC, et al. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health 2005; 8(Suppl 1): S9–S24.
17. Reilly MC, Barghout V, McBurney CR, et al. Effect of tegaserod on work and daily activity in IBS with constipation. Aliment Pharmacol Ther 2005; 22: 373–380.
18. Kessler RC, Barber C, Beck A, et al. The World Health Organization Health and Work Performance Questionnaire (HPQ). J Occup Environ Med 2003; 45(2): 156–174.
19. Tack J, van Outryve M, Beyens G, et al. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 2009; 58: 357–365.
20. World Bank. World Development Indicators database. Available at: http://siteresources.worldbank.org/DATASTATISTICS/Resources/GNIPC.pdf (2011, consulted July 2012).
21. Whitehead WE, Palsson OS, Levy RR, et al. Comorbidity in irritable bowel syndrome. Am J Gastroenterol 2007; 102: 2767–2776.
22. Breslow N. Tests of hypotheses in overdispersed Poisson regression and other quasi-likelihood models. J Am Stat Assoc 1990; 85: 565–571.
23. Scoppa V. Worker absenteeism and incentives: evidence from Italy, managerial and decision economics 2010; 31: 503–515.
24. Kronborg C, Handberg G and Axelsen F. Health care costs, work productivity and activity impairment in non-malignant chronic pain patients. Eur J Health Econ 2009; 10: 5–13.
25. Reilly MC, Gooch KL, Wong RL, et al. Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis. Rhuematology 2010; 49: 812–819.
26. Reilly MC, Bracco A, Ricci JF, et al. The validity and accuracy of the Work Productivity and Activity Impairment questionnaire – irritable bowel syndrome version (WPAI:IBS). Aliment Pharmacol Ther 2004; 20: 459–467.
27. Rodbard HW, Fox KM and Grandy S; Shield Study Group. Impact of obesity on work productivity and role disability in individuals with and at risk for diabetes mellitus. Am J Health Promot 2009; 23: 353–360.
28. Gross M, Beckenbauer U, Burkowitz J, et al. Impact of gastro-oesophageal reflux disease on work productivity despite therapy with proton pump inhibitors in Germany. Eur J Med Res 2010; 15: 124–130.
29. Zhang W, Bansback N, Boonen A, et al. Validity of the work productivity and activity impairment questionnaire – general health version in patients with rheumatoid arthritis. Arthritis Res Ther 2010; 12: R177.
30. Chen H, Blanc PD, Hayden ML, et al; TENOR Study Group. Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma. Value Health 2008; 11: 231–239.
31. Dean B, Aguilar D, Shapiro C, et al. Impaired health status, daily functioning, and work productivity in adults with excessive sleepiness. J Occup Environ Med 2010; 52: 144–149.
32. Bolge SC, Doan JF, Kannan H, et al. Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res 2009; 18: 415–422.
33. Beck A, Crain AL, Solberg LI, et al. Severity of depression and magnitude of productivity loss. Ann Fam Med 2011; 9: 305–311.
34. Sander GB, Mazzoleni LE, Francesconi CF, Balbinotto G, Mazzoleni F, Wortmann AC, Cardoso Ide Q, Klamt AL and Milbradt TC. Helicobacter Eradication Relief of Dyspetic Symptoms Trial Investigators. Influence of organic and functional dyspepsia on work productivity: the HEROES-DIP study. Value Health 2011; 14: S126–S129.
35. Camilleri M and Bharucha AE. Behavioural and new pharmacological treatments for constipation: getting the balance right. Gut 2010; 59: 1288–1296.
36. Camilleri M, Kerstens R, Rykx A, et al. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 2008; 358: 2344–2354.
37. Barsky AJ, Orav EJ and Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005; 62: 903–910.
38. Harris AM, Orav EJ, Bates DW, et al. Somatization increases disability independent of comorbidity. J Gen Intern Med 2009; 24: 155–161.
39. Spiegel BM, Kanwal F, Naliboff B, et al. The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome. Am J Gastroenterol 2005; 100: 2262–2273.
40. Longobardi T, Walker JR, Graff LA, et al. Health service utilization in IBD: comparison of self-report and administrative data. BMC Health Services Research 2011; 11: 137.